Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Wilson K

Department of Respiratory Diseases, Johns Hopkins University School of Medicine, United States
Publications

Mechanisms and Clinical Applications of Infliximab in Rheumatoid Arthritis and Crohn's Disease Management

Infliximab, a monoclonal antibody targeting tumor necrosis factor alpha (TNF-alpha), has revolutionized the management of chronic inflammatory diseases such as rheumatoid arthritis (RA) and Crohn's disease (CD). This review explores the intricate mechanisms through which Infliximab exerts its therapeutic effects and its clinical applications in the... Read More»

Wilson K

: J Pulm Res Dis 2024

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top